Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles
暂无分享,去创建一个
Federico E. Turkheimer | Gaia Rizzo | Mattia Veronese | Steven C. R. Williams | Fabio Sambataro | Alessandro Bertolino | Fernando Zelaya | Giulio Pergola | Mitul A. Mehta | Ottavia Dipasquale | Juergen Dukart | Pierluigi Selvaggi | Peter C. T. Hawkins | F. Turkheimer | J. Dukart | Steven C. R. Williams | M. Mehta | F. Sambataro | F. Zelaya | M. Veronese | G. Pergola | A. Bertolino | P. Selvaggi | O. Dipasquale | G. Rizzo | P. Hawkins
[1] P. Expert,et al. MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas , 2016, PloS one.
[2] Alan A. Wilson,et al. The Antipsychotics Olanzapine, Risperidone, Clozapine, and Haloperidol Are D2-Selective Ex Vivo but Not In Vitro , 2010, Neuropsychopharmacology.
[3] L. Hársing,et al. Vasoconstrictor 5-HT receptors in the smooth muscle of the rat middle cerebral artery. , 2012, European journal of pharmacology.
[4] Robert Tibshirani,et al. Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .
[5] D. Heeger,et al. In this issue , 2002, Nature Reviews Drug Discovery.
[6] G. Crelier,et al. Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Svensson,et al. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain , 1996, Psychopharmacology.
[8] R. Aebersold,et al. On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.
[9] B. Christian,et al. Brain imaging of 18F‐fallypride in normal volunteers: Blood analysis, distribution, test‐retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D‐2/D‐3 receptors , 2002, Synapse.
[10] Alexander L. Miller,et al. Results of phase 3 of the CATIE schizophrenia trial , 2009, Schizophrenia Research.
[11] Leon French,et al. A FreeSurfer view of the cortical transcriptome generated from the Allen Human Brain Atlas , 2015, Front. Neurosci..
[12] Jae Kyeong Jeong,et al. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory , 2012, Psychopharmacology.
[13] Paul M. Grasby,et al. Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning , 2003, NeuroImage.
[14] Ji-Kyung Choi,et al. Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling , 2006, NeuroImage.
[15] Paul Cumming,et al. Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects , 2008, NeuroImage.
[16] L. DeLisi,et al. Positron Emission Tomography in Schizophrenic Patients with and without Neuroleptic Medication , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] W. Vanduffel,et al. Neurovascular coupling to D 2 / D 3 dopamine receptor occupancy using simultaneous PET / functional MRI Citation , 2013 .
[18] A. J. Clark,et al. Methods of General Pharmacology , 1937 .
[19] Robert B. Innis,et al. Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot , 2016, NeuroImage.
[20] Allan R. Jones,et al. An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.
[21] B. Jansson,et al. In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy , 2016, Molecular Psychiatry.
[22] Carol A. Tamminga,et al. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia , 2005, Psychiatry Research: Neuroimaging.
[23] C. Halldin,et al. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. , 1995, The American journal of psychiatry.
[24] Roberto Viviani,et al. Components of variance in brain perfusion and the design of studies of individual differences: The baseline study , 2009, NeuroImage.
[25] Tobias C. Wood,et al. An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers , 2018, Human brain mapping.
[26] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[27] M. Cleij,et al. Differential occupancy of striatal versus extrastriatal dopamine D2/D3 receptors by the typical antipsychotic Haloperidol in man measured using [18F]-Fallypride PET , 2009, NeuroImage.
[28] Rolf A Heckemann,et al. The Predictive Power of Brain mRNA Mappings for in vivo Protein Density: A Positron Emission Tomography Correlation Study , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] P. Goldman-Rakic,et al. Dopaminergic regulation of cerebral cortical microcirculation , 1998, Nature Neuroscience.
[30] Maite Aznárez-Sanado,et al. Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers , 2011, British journal of pharmacology.
[31] B. Tabachnick,et al. Using Multivariate Statistics , 1983 .
[32] J. Kornhuber,et al. Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution. , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[33] W. Holmes Finch,et al. Distribution of Variables by Method of Outlier Detection , 2012, Front. Psychology.
[34] Ben D. Fulcher,et al. A practical guide to linking brain-wide gene expression and neuroimaging data , 2018, NeuroImage.
[35] Allan R. Jones,et al. Canonical Genetic Signatures of the Adult Human Brain , 2015, Nature Neuroscience.
[36] S. Kapur,et al. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.
[37] D. Greve,et al. A high-resolution in vivo atlas of the human brain's serotonin system. , 2016, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] N. Andreasen,et al. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia , 2001, Biological Psychiatry.
[39] M. K. Das,et al. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. , 1995, Nuclear medicine and biology.
[40] H. Meltzer. The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.
[41] Christopher H. Chatham,et al. Cerebral blood flow predicts differential neurotransmitter activity , 2017, bioRxiv.
[42] Bruce R. Rosen,et al. A receptor-based model for dopamine-induced fMRI signal , 2013, NeuroImage.
[43] S. Weisberg,et al. Residuals and Influence in Regression , 1982 .
[44] Krish D. Singh,et al. Which “neural activity” do you mean? fMRI, MEG, oscillations and neurotransmitters , 2012, NeuroImage.
[45] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[46] Alan A. Wilson,et al. Striatal Vs Extrastriatal Dopamine D2 Receptors in Antipsychotic Response—A Double-Blind PET Study in Schizophrenia , 2007, Neuropsychopharmacology.
[47] D R Medoff,et al. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.
[48] Meindert Danhof,et al. Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling. , 2009, Drug metabolism and pharmacokinetics.
[49] Alan A. Wilson,et al. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. , 1995, Life sciences.
[50] Mattia Veronese,et al. Quantification of [11C]PIB PET for Imaging Myelin in the Human Brain: A Test—Retest Reproducibility Study in High-Resolution Research Tomography , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] D. Attwell,et al. The neural basis of functional brain imaging signals , 2002, Trends in Neurosciences.
[52] Atholl Johnston,et al. Acute effects of single‐dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain , 2013, Human brain mapping.
[53] Hidehiko Takahashi,et al. Effects of the Antipsychotic Risperidone on Dopamine Synthesis in Human Brain Measured by Positron Emission Tomography with l-[β-11C]DOPA: A Stabilizing Effect for Dopaminergic Neurotransmission? , 2009, The Journal of Neuroscience.
[54] F. Turkheimer,et al. Brain shaving: adaptive detection for brain PET data , 2014, Physics in medicine and biology.
[55] C. Halldin,et al. Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.
[56] M. Rietschel,et al. Correlated gene expression supports synchronous activity in brain networks , 2015, Science.
[57] I. Kanno,et al. Human cerebral circulation: positron emission tomography studies , 2005, Annals of nuclear medicine.
[58] M. Tegner,et al. Antischizophrenic Drugs : Chronic Treatment Elevates Dopamine Receptor Binding in Brain , 2006 .
[59] G McKay,et al. Intersubject Variation in the Pharmacokinetics of Haloperidol and Reduced Haloperidol , 1989, Journal of clinical psychopharmacology.
[60] Alan C. Evans,et al. Biomarkers, designs, and interpretations of resting‐state fMRI in translational pharmacological research: A review of state‐of‐the‐Art, challenges, and opportunities for studying brain chemistry , 2017, Human brain mapping.
[61] Kalen J. Petersen,et al. [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease , 2018, NeuroImage: Clinical.
[62] N. Andreasen,et al. Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography , 1997, Neuropsychopharmacology.
[63] Jeih-San Liow,et al. Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] Alan A. Wilson,et al. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. , 2004, The American journal of psychiatry.
[65] Ciprian Catana,et al. Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI , 2016, Neuropsychopharmacology.
[66] S. Rombouts,et al. Dopamine-dependent architecture of cortico-subcortical network connectivity. , 2013, Cerebral cortex.
[67] Iain M McIntyre,et al. Brain distribution of selected antipsychotics in schizophrenia. , 2006, Forensic Science International.
[68] B. Abler,et al. Effects of amisulpride on human resting cerebral perfusion , 2013, Psychopharmacology.
[69] S. Snyder,et al. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.
[70] M. Kempton,et al. A systematic review and meta-analysis of the effects of antipsychotic medications on regional cerebral blood flow (rCBF) in schizophrenia: Association with response to treatment , 2014, Neuroscience & Biobehavioral Reviews.
[71] Ciprian Catana,et al. Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI , 2013, Proceedings of the National Academy of Sciences.
[72] A. Malhotra,et al. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. , 2015, JAMA psychiatry.
[73] N. Logothetis,et al. Neurophysiological investigation of the basis of the fMRI signal , 2001, Nature.
[74] Leon French,et al. Transcriptomic characterization of MRI contrast with focus on the T1-w/T2-w ratio in the cerebral cortex , 2017, NeuroImage.
[75] Mattia Veronese,et al. Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[76] J. Kornhuber,et al. Neuroleptic drugs in the human brain , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[77] Claus Svarer,et al. A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System , 2017, The Journal of Neuroscience.
[78] Siegfried Kasper,et al. Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging , 2018, NeuroImage.
[79] R. Greef,et al. Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms , 2011, The AAPS Journal.